This July 12, 2019 file photo shows the UnitedHealthcare headquarters in Minneapolis. UnitedHealth Group will spend nearly $8 billion in cash to add a health care technology company to its growing Optum business. UnitedHealth said Wednesday, Jan. 6, 2021 that it will add Change Healthcare to its OptumInsight segment and boost its ability to provide data analytics and revenue cycle management support, among other offerings. (AP Photo/Jim Mone, File)UnitedHealth Group will spend nearly $8 billion in cash to add a health care technology company to its growing Optum business.
UnitedHealth said Wednesday that it will add Change Healthcare to its OptumInsight segment and boost its ability to provide data analytics and revenue cycle management support, among other offerings.
Minnetonka, Minnesota-based UnitedHealth brings in most of its revenue through a health insurance business that covers about 48 million people. But its Optum segment generates bigger profit margins and provides a growing portion of the company’s operating earnings.
That business runs surgery centers, clinics and one of the nation's largest pharmacy benefit management operations. It also provides technology services and support through OptumInsight.
OptumInsight accounts for only about 3% of UnitedHealth’s revenue, but it also generates an operating profit margin of around 25%, Mizuho Securities analyst Ann Hynes said in a research note. She added that she views the Change deal positively.
UnitedHealth will pay $25.75 in cash for each share of Change Healthcare in a deal the companies expect to close in the second half of the year.
It still needs approval from Change shareholders and regulators. Private equity funds tied to The Blackstone Group own a roughly 20% stake in the Nashville, Tennessee, company, and they have already voted in favor of the deal.
Shares of UnitedHealth Group Inc. rose slightly to $346.80 in mid-morning trading Wednesday, while Change Healthcare jumped 31% to $23.93.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.
Get This Free Report
